https://www.marketscreener.com/quote/stock/ALBIREO-PHARMA-INC-31816183/news/Final-Results-of-Albireo-s-Phase-2-Study-of-A4250-in-Children-with-Cholestatic-Liver-Disease-Prese-25323518/?utm_source=telegram&utm_medium=social&utm_campaign=share